financetom
Business
financetom
/
Business
/
Sunrise Realty Trust Insider Bought Shares Worth $675,287, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sunrise Realty Trust Insider Bought Shares Worth $675,287, According to a Recent SEC Filing
Apr 1, 2025 2:53 PM

05:38 PM EDT, 04/01/2025 (MT Newswires) -- Leonard M Tannenbaum, 10% Owner, Director, Executive Chairman, on March 28, 2025, executed a purchase for 61,560 shares in Sunrise Realty Trust ( SUNS ) for $675,287. Following the Form 4 filing with the SEC, Tannenbaum has control over a total of 3,239,593 common shares of the company, with 2,711,322 shares held directly and 528,271 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2012706/000120046125000018/xslF345X05/wk-form4_1743543235.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lululemon Faces More Profit Pressure After Steep Guidance Drop, Morgan Stanley Says
Lululemon Faces More Profit Pressure After Steep Guidance Drop, Morgan Stanley Says
Sep 30, 2025
11:05 AM EDT, 09/30/2025 (MT Newswires) -- Lululemon athletica's (LULU) sharper-than-expected earnings guidance cut may signal further downside over the next year, Morgan Stanley said Monday in a note. Earlier this month, lululemon projected diluted full-year fiscal earnings per share of $12.77 to $12.97, down from $14.58 to $14.78, a bigger decline than forecast, Morgan Stanley said. Morgan Stanley trimmed...
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says
Sep 30, 2025
11:06 AM EDT, 09/30/2025 (MT Newswires) -- IO Biotech ( IOBT ) faces increased near-term uncertainty after reporting that the US Food and Drug Administration recommended it not submit a biologics license application for cylembio in melanoma after a phase 3 trial fell narrowly short of statistical significance, Morgan Stanley said in a Tuesday report. The biopharmaceutical company said Monday...
--Street Color: Robinhood Markets Mulls Roll Out of Prediction Markets Product Outside US
--Street Color: Robinhood Markets Mulls Roll Out of Prediction Markets Product Outside US
Sep 30, 2025
11:01 AM EDT, 09/30/2025 (MT Newswires) -- Price: 139.77, Change: +3.04, Percent Change: +2.23 ...
Looking At Amazon.com's Recent Unusual Options Activity
Looking At Amazon.com's Recent Unusual Options Activity
Sep 30, 2025
Deep-pocketed investors have adopted a bearish approach towards Amazon.com ( AMZN ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMZN usually suggests something big is about to happen. We gleaned this information from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved